GlyRS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of GlyRS monoclonal antibodies for investigating Glycyl-tRNA synthetase (GlyRS) in cellular processes. GlyRS monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycyl-tRNA synthetase is crucial for protein synthesis, as it catalyzes the attachment of glycine to its corresponding tRNA, ensuring the accurate translation of genetic information into functional proteins. GlyRS maintains cellular homeostasis through its essential role in protein synthesis and has been linked to various disease states. Research focusing on GlyRS can reveal important insights about protein synthesis mechanisms and their effects on cellular health. Multiple detection formats are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates. Investigating GlyRS expression and activity patterns can lead to better understanding of disease progression and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge about GlyRS and its impact on human health.